6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
CPT, DSM, and ICD
ICD:
The International Classification of diseases and other Health Problems (ICD) codes are used in conjunction with CPT codes to submit insurance claims. They were developed by the World Health Organization (WHO). The Evaluation and Edition Of the Diagnostic contains the DSM-5 codes.
CPT:
Compulsion Treatment Charging CPT Code #1: H0001HF The CPT code for typically “H0001” and the modifier for usually “HF.” H0001 alludes to time went through completing sedate and/or liquor evaluations with clients within the course of treatment for substance utilize disorder.
DSM:
The term "addiction" will be reintroduced in the DSM-V. The claim is that physiological dependency, as opposed to the obsessive substance seeking that is typical of addiction, is a normal response of the central nervous system to a substance.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States